# Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

Study · id `cardio:ct-nct06096246` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06096246](<https://clinicaltrials.gov/study/NCT06096246>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06096246

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 208 participants.

## Technical summary

Registry record NCT06096246. Randomized; double masking; primary purpose treatment. Start 2024-07-26 (actual); primary completion 2027-07-26 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 208 participants (planned count; ClinicalTrials.gov record NCT06096246, source copy `cardio:ctgov-nct06096246-2026-09-22`, retrieved 2026-10-26)
- Started: 2024-07-26 (actual) (ClinicalTrials.gov record NCT06096246, source copy `cardio:ctgov-nct06096246-2026-09-22`, retrieved 2026-10-26)
- Primary completion: 2027-07-26 (anticipated) (ClinicalTrials.gov record NCT06096246, source copy `cardio:ctgov-nct06096246-2026-09-22`, retrieved 2026-10-26)
- Completion: 2027-12-05 (anticipated) (ClinicalTrials.gov record NCT06096246, source copy `cardio:ctgov-nct06096246-2026-09-22`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT06096246, source copy `cardio:ctgov-nct06096246-2026-09-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06096246-2026-09-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
- Acronym: ORBICA-AF
- Condition: Persistent Atrial Fibrillation
- Condition: Cardiac Arrhythmia
- Condition: Catheter Ablation
- Intervention (Procedure): Pulmonary vein isolation
- Intervention (Procedure): DC Cardioversion
- Intervention (Device): Implantable loop recorder
- Intervention (Procedure): Femoral sheath insertion
- Lead sponsor: Barts & The London NHS Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Barts & The London NHS Trust (`cardio:org-barts-the-london-nhs-trust`)

## Provenance

Content hash: eca12c648236f34ae4cfd99975e3fa85ef83556e0f6df2531af3c4040557978e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
